StockData
Champions Oncology, Inc. logo

Champions Oncology, Inc. (CSBR) stock

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30238% above fair value
$4.59−0.09 (-1.89%)

Close on Nov 17, 2026Market cap $63.91MP/E –Yield –

Champions Oncology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Champions Oncology's revenue for the twelve months ending Jul 31, 2026 was $60.66M, up 6.7% year over year. For fiscal 2026 it was $59.43M, up 4.4% from the year before. Over ten years it grew 18.2% a year on average. The highest annual figure on record is $59.43M in fiscal 2026.

Annual revenue

PeriodPeriod endValueChange
FY2026Apr 30, 2026$59.43M+4.4%
FY2025Apr 30, 2025$56.94M+13.5%
FY2024Apr 30, 2024$50.16M-6.9%
FY2023Apr 30, 2023$53.87M+9.7%
FY2022Apr 30, 2022$49.11M+19.7%
FY2021Apr 30, 2021$41.04M+27.8%
FY2020Apr 30, 2020$32.12M+1007.7%
FY2019Apr 30, 2019$2.90M-85.7%
FY2018Apr 30, 2018$20.24M+31.3%
FY2017Apr 30, 2017$15.41M+37.8%
FY2016Apr 30, 2016$11.18M+26.2%
FY2015Apr 30, 2015$8.86M-23.3%
FY2014Apr 30, 2014$11.55M+38.8%
FY2013Apr 30, 2013$8.32M+16.4%
FY2012Apr 30, 2012$7.15M+3.9%
FY2011Apr 30, 2011$6.88M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$15.23M+8.8%
Q4 FY2026CQ1 2026Apr 30, 2026$13.84M+12.0%
Q3 FY2026CQ4 2025Jan 31, 2026$16.56M-2.8%
Q2 FY2026CQ3 2025Oct 31, 2025$15.04M+11.5%
Q1 FY2026CQ2 2025Jul 31, 2025$14.00M-0.5%
Q4 FY2025CQ1 2025Apr 30, 2025$12.36M-11.8%
Q3 FY2025CQ4 2024Jan 31, 2025$17.04M+41.8%
Q2 FY2025CQ3 2024Oct 31, 2024$13.49M+16.6%
Q1 FY2025CQ2 2024Jul 31, 2024$14.06M+11.9%
Q4 FY2024CQ1 2024Apr 30, 2024$14.00M+7.1%
Q3 FY2024CQ4 2023Jan 31, 2024$12.02M-5.9%
Q2 FY2024CQ3 2023Oct 31, 2023$11.57M-19.0%
Q1 FY2024CQ2 2023Jul 31, 2023$12.56M-8.6%
Q4 FY2023CQ1 2023Apr 30, 2023$13.07M+1.5%
Q3 FY2023CQ4 2022Jan 31, 2023$12.77M-3.2%
Q2 FY2023CQ3 2022Oct 31, 2022$14.28M+21.2%
Q1 FY2023CQ2 2022Jul 31, 2022$13.75M+22.1%
Q4 FY2022CQ1 2022Apr 30, 2022$12.88M+21.9%
Q3 FY2022CQ4 2021Jan 31, 2022$13.19M+22.0%
Q2 FY2022CQ3 2021Oct 31, 2021$11.79M+16.5%
Q1 FY2022CQ2 2021Jul 31, 2021$11.25M+17.9%
Q4 FY2021CQ1 2021Apr 30, 2021$10.56M+20.8%
Q3 FY2021CQ4 2020Jan 31, 2021$10.81M+20.0%
Q2 FY2021CQ3 2020Oct 31, 2020$10.12M+32.7%
Q1 FY2021CQ2 2020Jul 31, 2020$9.55M+41.7%
Q4 FY2020CQ1 2020Apr 30, 2020$8.75M+13.3%
Q3 FY2020CQ4 2019Jan 31, 2020$9.01M+40.2%
Q2 FY2020CQ3 2019Oct 31, 2019$7.63M+13.9%
Q1 FY2020CQ2 2019Jul 31, 2019$6.74M+8.2%
Q4 FY2019CQ1 2019Apr 30, 2019$7.72M+56.8%
Q3 FY2019CQ4 2018Jan 31, 2019$6.43M+26.5%
Q2 FY2019CQ3 2018Oct 31, 2018$6.69M+28.6%
Q1 FY2019CQ2 2018Jul 31, 2018$6.23M+23.7%
Q4 FY2018CQ1 2018Apr 30, 2018$4.92M+32.3%
Q3 FY2018CQ4 2017Jan 31, 2018$5.08M+42.6%
Q2 FY2018CQ3 2017Oct 31, 2017$5.20M+16.7%
Q1 FY2018CQ2 2017Jul 31, 2017$5.03M–
Q4 FY2017CQ1 2017Apr 30, 2017$3.72M–
Q3 FY2017CQ4 2016Jan 31, 2017$3.57M–
Q2 FY2017CQ3 2016Oct 31, 2016$4.46M–

More Champions Oncology figures

See a number that looks wrong?